Skip to main content
logo
BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.270
-0.030 (-1.30%)
At close: Apr 24, 2026, 4:00 PM EDT
2.290
+0.020 (0.88%)
After-hours: Apr 24, 2026, 7:08 PM EDT

BioLineRx Revenue

In the year 2025, BioLineRx had annual revenue of $1.18M, down -95.92%. BioLineRx had revenue of $194.00K in the quarter ending December 31, 2025, a decrease of -98.35%.

Revenue (ttm)
$1.18M
Revenue Growth
-95.92%
P/S Ratio
9.63
Revenue / Employee
$49,167
Employees
24
Market Cap
11.36M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.18M-27.76M-95.92%
Dec 31, 202428.94M24.14M502.92%
Dec 31, 20234.80M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Traws Pharma2.79M
Cyclerion Therapeutics2.07M
CytoMed Therapeutics669.28K
Aprea Therapeutics285.76K
Kiora Pharmaceuticals20.00K
Revenue Rankings

BLRX News

More News